ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Stoke Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Stoke Therapeutics, INC. (Stoke Therapeutics, INC. 401(k) Retirement Plan · EIN 47-1144582 · PN 001): $14.01M net assets, 128 active participants, and $3.05 per $10,000 (3.05 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorStoke Therapeutics, INC.
Filing IdentifierStoke Therapeutics, INC. 401(k) Retirement Plan · EIN 47-1144582 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$14.01M
Active Participants128
Direct Admin Fee Rate$3.05 per $10,000 (3.05 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($192,534, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI